CONAGRA BRANDS INC. Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Conagra Brands Inc. quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Conagra Brands Inc. Goodwill for the quarter ending August 25, 2024 was $10.8B, a 3.76% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $10.8B -$420M -3.76% Aug 25, 2024 10-Q 2024-10-02
Q2 2024 $10.6B -$527M -4.74% May 26, 2024 10-Q 2024-10-02
Q1 2024 $11.1B -$68.2M -0.61% Feb 25, 2024 10-Q 2024-04-04
Q4 2023 $11.1B -$70.8M -0.63% Nov 26, 2023 10-Q 2024-01-04
Q3 2023 $11.2B -$5.4M -0.05% Aug 27, 2023 10-Q 2023-10-05
Q2 2023 $11.1B -$146M -1.3% May 28, 2023 10-K 2024-07-11
Q1 2023 $11.2B -$154M -1.36% Feb 26, 2023 10-Q 2023-04-05
Q4 2022 $11.2B -$152M -1.34% Nov 27, 2022 10-Q 2023-01-05
Q3 2022 $11.2B -$186M -1.63% Aug 28, 2022 10-Q 2022-10-06
Q2 2022 $11.3B -$83.7M -0.74% May 29, 2022 10-K 2024-07-11
Q1 2022 $11.3B -$63.2M -0.56% Feb 27, 2022 10-Q 2022-04-07
Q4 2021 $11.3B -$62.4M -0.55% Nov 28, 2021 10-Q 2022-01-06
Q3 2021 $11.4B -$70.4M -0.62% Aug 29, 2021 10-Q 2021-10-07
Q2 2021 $11.3B +$12M +0.11% May 31, 2021 10-K 2023-07-13
Q1 2021 $11.4B -$47.5M -0.42% Feb 28, 2021 10-Q 2021-04-08
Q4 2020 $11.4B -$48.5M -0.42% Nov 29, 2020 10-Q 2021-01-07
Q3 2020 $11.4B -$22.7M -0.2% Aug 30, 2020 10-Q 2020-10-06
Q2 2020 $11.3B -$33.7M -0.3% May 31, 2020 10-K 2022-07-21
Q1 2020 $11.4B +$93.3M +0.82% Feb 23, 2020 10-Q 2020-03-31
Q4 2019 $11.4B +$276M +2.47% Nov 24, 2019 10-Q 2020-01-02
Q3 2019 $11.5B +$6.96B +155% Aug 25, 2019 10-Q 2019-10-01
Q2 2019 $11.4B +$6.88B +154% May 26, 2019 10-K 2021-07-23
Q1 2019 $11.3B +$6.84B +152% Feb 24, 2019 10-Q 2019-04-02
Q4 2018 $11.2B +$6.71B +151% Nov 25, 2018 10-Q 2019-01-03
Q3 2018 $4.5B +$198M +4.6% Aug 26, 2018 10-Q 2018-10-02
Q2 2018 $4.48B +$196M +4.59% May 27, 2018 10-K 2020-07-24
Q1 2018 $4.51B +$255M +6% Feb 25, 2018 10-Q 2018-04-03
Q4 2017 $4.46B +$208M +4.9% Nov 26, 2017 10-Q 2018-01-04
Q3 2017 $4.3B -$88.9M -2.03% Aug 27, 2017 10-Q 2017-10-03
Q2 2017 $4.28B -$35.1M -0.81% May 28, 2017 10-K 2019-07-19
Q1 2017 $4.25B -$431M -9.19% Feb 26, 2017 10-Q 2017-04-04
Q4 2016 $4.25B -$437M -9.32% Nov 27, 2016 10-Q 2017-01-04
Q3 2016 $4.39B -$299M -6.37% Aug 28, 2016 10-Q 2016-10-04
Q2 2016 $4.32B -$12.7M -0.29% May 29, 2016 10-K 2018-07-20
Q1 2016 $4.68B -$1.62B -25.7% Feb 28, 2016 10-Q 2016-04-07
Q4 2015 $4.69B -$2.93B -38.5% Nov 29, 2015 10-Q 2016-01-06
Q3 2015 $4.69B -$3.15B -40.2% Aug 30, 2015 10-Q 2015-10-06
Q2 2015 $4.33B -$220M -4.84% May 31, 2015 10-K 2017-07-21
Q1 2015 $6.31B -$2.12B -25.2% Feb 22, 2015 10-Q 2015-03-30
Q4 2014 $7.62B -$839M -9.92% Nov 23, 2014 10-Q 2014-12-29
Q3 2014 $7.84B -$579M -6.88% Aug 24, 2014 10-Q 2014-09-29
Q2 2014 $4.55B -$3.87B -46% May 25, 2014 10-K 2016-07-15
Q1 2014 $8.43B +$57.9M +0.69% Feb 23, 2014 10-Q 2014-04-01
Q4 2013 $8.46B +$4.35B +106% Nov 24, 2013 10-Q 2013-12-31
Q3 2013 $8.42B +$4.25B +102% Aug 25, 2013 10-Q 2013-10-01
Q2 2013 $8.42B +$4.41B +110% May 26, 2013 10-K 2015-07-17
Q1 2013 $8.37B +$4.44B +113% Feb 24, 2013 10-Q 2013-04-03
Q4 2012 $4.11B +$503M +14% Nov 25, 2012 10-Q 2012-12-28
Q3 2012 $4.17B +$558M +15.5% Aug 26, 2012 10-Q 2012-09-28
Q2 2012 $4.01B +$399M +11.1% May 27, 2012 10-K 2014-07-16
Q1 2012 $3.93B +$316M +8.76% Feb 26, 2012 10-Q 2012-03-30
Q4 2011 $3.6B -$4.4M -0.12% Nov 27, 2011 10-Q 2011-12-30
Q3 2011 $3.61B +$7M +0.19% Aug 28, 2011 10-Q 2011-09-30
Q2 2011 $3.61B +$59.5M +1.68% May 29, 2011 10-K 2013-07-19
Q1 2011 $3.61B +$117M +3.34% Feb 27, 2011 10-Q 2011-04-04
Q4 2010 $3.61B Nov 28, 2010 10-Q 2011-01-03
Q3 2010 $3.6B Aug 29, 2010 10-Q 2010-10-01
Q2 2010 $3.55B May 30, 2010 10-K 2012-07-20
Q1 2010 $3.49B Feb 28, 2010 10-Q 2010-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.